Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Deleterious BRCA2 Gene Mutation

Tundra lists 3 Deleterious BRCA2 Gene Mutation clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT03586661

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

This phase Ib trial studies the best dose and side effects of niraparib and copanlisib in treating patients with endometrial, ovarian, primary peritoneal, or fallopian tube cancer that has come back. Niraparib and copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-03-11

1 state

Deleterious BRCA1 Gene Mutation
Deleterious BRCA2 Gene Mutation
Endometrial Adenocarcinoma
+8
ACTIVE NOT RECRUITING

NCT02760849

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

This phase II trial studies how well surgery works in preventing ovarian cancer in patients with genetic mutations at risk of ovarian cancer. Risk reducing salpingo oophorectomy (RRSO) is surgery to remove the fallopian tubes and ovaries at the same time. Interval salpingectomy with delayed oophorectomy (ISDO) is surgery to remove the fallopian tubes. It is not known whether ISDO works better than RRSO at lowering risk of ovarian cancer and improving the sexual function and psychosocial well-being in patients with genetic mutation.

Gender: FEMALE

Ages: 30 Years - 50 Years

Updated: 2026-01-07

8 states

Deleterious BARD1 Gene Mutation
Deleterious BRCA1 Gene Mutation
Deleterious BRCA2 Gene Mutation
+11
ACTIVE NOT RECRUITING

NCT03546972

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

This pilot trial studies how well a diabetes prevention program with or without hunger training works in helping to lower breast cancer risk in obese participants. A diabetes prevention program involves learning about and receiving materials on different strategies to encourage weight loss, and hunger training involves learning how to recognize hunger. It is not yet known whether adding hunger training to a diabetes prevention program helps participants control their weight that could reduce the risk of some cancers.

Gender: FEMALE

Ages: 30 Years - 70 Years

Updated: 2025-10-14

1 state

Deleterious BRCA1 Gene Mutation
Deleterious BRCA2 Gene Mutation
Ductal Breast Carcinoma In Situ
+3